Auf dieser Seite
01HALO Preis
02Momentaufnahme
03Chart
05Über uns
06Performance
07Bewertung & Kennzahlen
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
25Handelssignale
26Meine Kennzahlen
HALO Halozyme Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 6, 2026
$108,31
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$61,2352-Wochen-Tief
$116,8552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$12.35B
P/E (TTM)
31.7
EPS (TTM)
$3.42
Umsatz (TTM)
$1.66B
Ihre Abzeichen
52W-Spanne
$61–$117
Analystenbewertung
BUY
Kursziel
$100
P/E
31.7
ROE
173.7%
Nettogewinnmarge
24.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
HALO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$108.31
Marktkapitalisierung (MRQ)
$12.35B
P/E (TTM)
31.7
EPS (TTM)
$3.42
Umsatz (TTM)
$1.66B
ROE (TTM)
173.7%
Verschuldungsgrad (MRQ)
15.0
52W-Spanne
$61–$117
HALO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Halozyme Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter423
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$1.40B2016-12-31 → 2025-12-31
EPS$2.562016-12-31 → 2025-12-31
Freier Cashflow$645M2016-12-31 → 2025-12-31
Nettogewinnmarge24.9%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | HALO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 31.75-Jahres-Durchschnitt ≈22.4 | ≈22.4 | 24.7 | Unterbewertet | |
| P/S (TTM) | 7.45-Jahres-Durchschnitt ≈8.2 | ≈8.2 | 9.7 | Unterbewertet | |
| K/B (MRQ) | 86.15-Jahres-Durchschnitt ≈61.6 | ≈61.6 | 11.3 | Überbewertet | |
| EV / EBITDA | 30.75-Jahres-Durchschnitt ≈21.3 | ≈21.3 | · | · | |
| Kurs / FCF (TTM) | 15.35-Jahres-Durchschnitt ≈17.7 | ≈17.7 | · | · | |
| Kurs / Cashflow (TTM) | 15.15-Jahres-Durchschnitt ≈17.4 | ≈17.4 | 13.8 | Unterbewertet | |
| EV / Revenue (EV / Umsatz) | 10.65-Jahres-Durchschnitt ≈9.9 | ≈9.9 | · | · | |
| EV / FCF | 22.95-Jahres-Durchschnitt ≈21.3 | ≈21.3 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -15.9 | · | · | · | |
| PEG Ratio (PEG-Ratio) | ≈1.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | HALO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 35.9%5-Jahres-Durchschnitt ≈46.3% | ≈46.3% | 11.2% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 36.8%5-Jahres-Durchschnitt ≈47.2% | ≈47.2% | 11.2% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 35.1%5-Jahres-Durchschnitt ≈44.8% | ≈44.8% | 6.2% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 24.9%5-Jahres-Durchschnitt ≈44.4% | ≈44.4% | 4.5% | Spitzenklasse | |
| ROA (TTM) | 17.9%5-Jahres-Durchschnitt ≈22.9% | ≈22.9% | -3.8% | Spitzenklasse | |
| ROE (TTM) | 173.7%5-Jahres-Durchschnitt ≈152.8% | ≈152.8% | 17.1% | Spitzenklasse | |
| ROIC | 14.5%5-Jahres-Durchschnitt ≈22.0% | ≈22.0% | 14.3% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | HALO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 15.05-Jahres-Durchschnitt ≈15.8 | ≈15.8 | 0.4 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 2.75-Jahres-Durchschnitt ≈6.5 | ≈6.5 | 3.0 | Im Einklang | |
| Quick Ratio | 3.25-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 1.9 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 13.55-Jahres-Durchschnitt ≈15.7 | ≈15.7 | 0.6 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | HALO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 37.5%5-Jahres-Durchschnitt ≈40.0% | ≈40.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 28.4%5-Jahres-Durchschnitt ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 39.2% | · | · | · | |
| EPS YoY (EPS VjV) | -25.4%5-Jahres-Durchschnitt ≈47.5% | ≈47.5% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -28.6%5-Jahres-Durchschnitt ≈46.1% | ≈46.1% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 21.1%5-Jahres-Durchschnitt ≈20.4% | ≈20.4% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 23.0% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 16.2%5-Jahres-Durchschnitt ≈16.4% | ≈16.4% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 19.7% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | HALO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.6 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 1.45-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 1.1 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 3.95-Jahres-Durchschnitt ≈4.2 | ≈4.2 | 5.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$3.3M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-8.1%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 11, 2026 | $2.28 | $1.87 | 21.7% |
| 31. März 2026 | Mai 12, 2026 | $1.60 | $1.56 | 2.5% |
| 31. Dezember 2025 | $-0.24 | $2.24 | -110.7% | |
| 30. September 2025 | $1.72 | $1.66 | 3.6% | |
| 30. Juni 2025 | $1.54 | $1.29 | 19.3% | |
| 31. März 2025 | $1.11 | $0.97 | 14.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.02B | $829M | $660M | $443M | $268M | $196M | $152M | $317M | $147M | $135M | $75M | |
| Cost of Revenue | $229M | $159M | $192M | $139M | $81M | $43M | $46M | $10M | $31M | $33M | $29M | $23M | |
| R&D Expense | · | $79M | $76M | $67M | $36M | $34M | $141M | $150M | $151M | $151M | $93M | $80M | |
| SG&A Expense | $207M | $154M | $149M | $144M | $50M | $46M | $77M | $61M | $54M | $46M | $40M | $36M | |
| Operating Expenses | $928M | $464M | $492M | $393M | $167M | $123M | $264M | · | · | $230M | $163M | $138M | |
| Operating Income | $469M | $551M | $338M | $268M | $276M | $144M | $-68M | $-69M | $81M | $-83M | $-27M | $-63M | |
| Interest Expense | · | · | $19M | $17M | $8M | $20M | $12M | $18M | $22M | $20M | $5M | $6M | |
| Other Non-op | $21M | $24M | $16M | $1M | $1M | $5M | $7M | $8M | $3M | $1M | $422.0K | · | |
| Pretax Income | $467M | $557M | $348M | $249M | $249M | $129M | $-72M | $-80M | $62M | $-102M | $-32M | $-68M | |
| Income Tax | $150M | $113M | $67M | $47M | $-154M | $217.0K | $-11.0K | $537.0K | $-1M | $1M | $0 | $0 | |
| Net Income | $317M | $444M | $282M | $202M | $403M | $129M | $-72M | $-80M | $63M | $-103M | $-32M | $-68M | |
| EPS (Basic) | $2.64 | $3.50 | $2.13 | $1.48 | $2.86 | $0.95 | $-0.50 | $-0.56 | $0.46 | $-0.81 | $-0.25 | · | |
| EPS (Diluted) | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 | $0.91 | $-0.50 | $-0.56 | $0.45 | $-0.81 | $-0.25 | · | |
| Shares (Basic) | 119,840,000 | 126,827,000 | 131,927,000 | 136,844,000 | 140,646,000 | 136,206,000 | 144,329,000 | 143,599,000 | 136,419,000 | 127,964,000 | 126,704,000 | · | |
| Shares (Diluted) | 123,904,000 | 129,424,000 | 134,197,000 | 140,608,000 | 146,796,000 | 141,463,000 | 144,329,000 | 143,599,000 | 139,068,000 | 127,964,000 | 126,704,000 | · | |
| EBITDA | $480M | $562M | $349M | $274M | $279M | $148M | $-64M | $-67M | $83M | $-81M | $-26M | $-61M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $134M | $116M | $118M | $234M | $119M | $148M | $120M | $58M | $169M | $67M | $43M | $61M | |
| Short-term Investments | · | · | · | · | · | · | $301M | $297M | $300M | $138M | $65M | $74M | |
| Receivables | $426M | $288M | $233M | $187M | $91M | $98M | $59M | $30M | $22M | $16M | $32M | $9M | |
| Inventory | $176M | $142M | $128M | $100M | $54M | $61M | $29M | $23M | $5M | $15M | $9M | $6M | |
| Prepaid Expense | $65M | $39M | $49M | $45M | $40M | $28M | $33M | $21M | $14M | $21M | $22M | $10M | |
| Current Assets | $825M | $1.09B | $746M | $739M | $926M | $555M | $543M | $428M | $510M | $257M | $172M | $161M | |
| PP&E (Net) | $44M | $41M | $38M | $35M | $7M | $7M | $11M | $7M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | $78M | $66M | $58M | $50M | $20M | $19M | $18M | $24M | $17M | $16M | $14M | $12M | |
| Accum. Depreciation | $33M | $25M | $20M | $15M | $13M | $12M | · | $16M | $14M | $12M | $10M | $9M | |
| Goodwill | $580M | $417M | $417M | $409M | $0 | · | · | · | · | · | · | · | |
| Intangibles | $981M | $402M | $473M | $547M | $0 | · | · | · | · | · | · | · | |
| Total Assets | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $580M | $566M | $440M | $520M | $262M | $182M | $166M | |
| Accounts Payable | $21M | $10M | $12M | $18M | $2M | $2M | $6M | $4M | $8M | $4M | $4M | $3M | |
| Accrued Liabilities | $156M | $129M | $101M | $100M | $24M | $20M | $56M | $50M | $40M | $29M | $27M | $14M | |
| Current Liabilities | $177M | $139M | $112M | $131M | $117M | $421M | $86M | $149M | $131M | $55M | $62M | $24M | |
| Deferred Tax | $43M | $0 | $0 | · | $0 | · | $16M | $858.0K | $173.0K | $340.0K | $380.0K | $194.0K | |
| Other Non-current Liabilities | $114M | $55M | $38M | $33M | $544.0K | $3M | $4M | $2M | $814.0K | $358.0K | $4M | $3M | |
| Total Liabilities | $2.48B | $1.70B | $1.65B | $1.67B | · | · | · | · | · | · | · | · | |
| Long-term Debt | $2.14B | $1.51B | $1.50B | $1.51B | $787M | $0 | $383M | $35M | $125M | $199M | $28M | $50M | |
| Total Debt | $2.14B | $1.51B | $1.50B | $1.51B | $877M | $397M | $403M | $126M | $202M | $217M | $50M | $50M | |
| Common Stock | $118.0K | $123.0K | $127.0K | $135.0K | $138.0K | $135.0K | $137.0K | $145.0K | $143.0K | $130.0K | $128.0K | $126.0K | |
| Retained Earnings | $55M | $360M | $91M | $143M | $-59M | $-475M | $-604M | $-531M | $-522M | $-585M | $-483M | $-450M | |
| AOCI | $-18M | $4M | $-9M | $-922.0K | $-620.0K | $22.0K | $240.0K | $-277.0K | $-450.0K | $-6.0K | $-99.0K | $-41.0K | |
| Stockholders' Equity | $49M | $364M | $84M | $170M | $197M | $151M | $92M | $249M | $208M | $-32M | $43M | $41M | |
| Liabilities + Equity | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $580M | $566M | $440M | $520M | $262M | $182M | $166M | |
| Shares Outstanding | 117,782,000 | 123,138,000 | 126,770,000 | 135,154,000 | 137,498,000 | 135,030,000 | 136,712,580 | 144,725,164 | 142,789,000 | 129,502,000 | 128,152,000 | 125,721,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $10M | $11M | $6M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $52M | $43M | $37M | $24M | $21M | $17M | $35M | $36M | $31M | $26M | $21M | $15M | |
| Amort. of Intangibles | $77M | $71M | $74M | $43M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $272M | $-19M | $59M | $7M | $-127M | $-94M | $-52M | $-7M | $38M | $25M | $-27M | $4M | |
| Operating Cash Flow | $652M | $479M | $389M | $240M | $299M | $55M | $-85M | $-50M | $134M | $-50M | $-37M | $-48M | |
| CapEx | $7M | $11M | $15M | $5M | $1M | $3M | $4M | $5M | $1M | $3M | $2M | $1M | |
| Investing Cash Flow | $-546M | $-263M | $-97M | $-487M | $-406M | $78M | $-6M | $2M | $-164M | $-77M | $6M | $-33M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $135M | $0 | $0 | $108M | |
| Stock Repurchased | $342M | $250M | $402M | $200M | $350M | $150M | $200M | $0 | $0 | · | · | · | |
| Net Stock Activity | $-342M | $-250M | $-402M | $-200M | $-350M | $-150M | $-200M | $0 | $135M | $0 | $0 | $108M | |
| Financing Cash Flow | $-85M | $-219M | $-408M | $362M | $78M | $-106M | $153M | $-64M | $132M | $151M | $13M | $115M | |
| Net Change in Cash | $21M | $-3M | $-116M | $115M | $-29M | $28M | $62M | $-111M | $102M | $23M | $-18M | $34M | |
| Taxes Paid | $135M | $81M | $32M | $16M | $-375.0K | $180.0K | · | · | · | · | · | · | |
| Free Cash Flow | $645M | $468M | $373M | $235M | $298M | $53M | $-89M | $-54M | $133M | $-54M | $-39M | $-49M | |
| Levered FCF | · | · | $358M | $222M | $286M | $33M | $-101M | $-72M | $110M | $-74M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 33.6% | 54.3% | 40.7% | 40.5% | 62.2% | · | · | -45.6% | 25.6% | -56.7% | -20.3% | -83.7% | |
| Net Margin | 22.7% | 43.7% | 34.0% | 30.6% | 90.8% | · | · | -52.9% | 19.9% | -70.2% | -23.9% | -90.8% | |
| Pretax Margin | 33.4% | 54.9% | 42.0% | 37.7% | 56.1% | · | · | -52.5% | 19.5% | -69.4% | · | · | |
| EBITDA Margin | 34.4% | 55.3% | 42.0% | 41.5% | 62.9% | · | · | -44.1% | 26.3% | -55.1% | -19.1% | -81.3% | |
| ROA | 13.8% | 23.4% | 15.8% | 13.7% | 47.8% | 22.5% | -14.4% | -16.7% | 16.1% | -46.5% | -18.5% | -51.1% | |
| ROE | 166.1% | 108.8% | 169.1% | 151.5% | 168.3% | 103.2% | -42.9% | -32.9% | 71.6% | -1959.0% | -76.4% | -640.2% | |
| ROIC | 14.5% | 23.5% | 17.2% | 13.0% | 41.6% | 26.3% | -13.7% | -18.6% | 20.2% | -45.7% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 7.8 | 6.6 | 5.7 | 7.9 | 1.3 | 6.3 | 2.9 | 3.9 | 4.7 | 2.8 | 6.6 | |
| Quick Ratio | 3.2 | 2.9 | 1.1 | 3.6 | 1.8 | 0.6 | 5.6 | 2.6 | 3.7 | 4.0 | 2.3 | 6.0 | |
| Debt / Equity | 43.9 | 4.1 | 17.9 | 8.9 | 4.5 | 2.6 | 4.4 | 0.5 | 1.0 | -6.7 | 1.2 | 1.2 | |
| LT Debt / Equity | 43.9 | 4.1 | 17.9 | 8.8 | 4.0 | 0.0 | 4.2 | 0.1 | 0.6 | -6.1 | 0.7 | 1.2 | |
| Interest Coverage | · | · | 18.0 | 15.8 | 36.7 | 7.1 | -5.8 | -3.8 | 3.7 | -4.2 | -5.3 | -11.3 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 | · | · | 0.3 | 0.8 | 0.7 | 0.8 | 0.6 | |
| Inventory Turnover | 1.4 | 1.2 | 1.7 | 1.8 | 1.4 | 1.0 | 1.8 | 0.7 | 3.2 | 2.8 | 3.7 | 3.6 | |
| Receivables Turnover | 3.9 | 3.9 | · | 4.1 | 4.7 | · | · | 5.8 | 16.7 | 6.1 | 6.5 | 8.3 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.41 | $2.95 | $0.66 | $1.26 | $1.43 | $1.12 | $0.67 | $1.74 | $1.46 | $-0.25 | $0.34 | $0.33 | |
| Revenue / Share | $11.27 | $7.84 | $6.18 | $4.69 | $3.02 | · | · | $1.06 | $2.28 | · | · | · | |
| Cash Flow / Share | $5.26 | $3.70 | $2.90 | $1.71 | $2.04 | $0.39 | $-0.59 | $-0.34 | $0.96 | · | · | · | |
| Cash / Share | $1.14 | $0.94 | $0.93 | $1.73 | $0.86 | $1.09 | $0.88 | $0.41 | $1.18 | $0.52 | $0.34 | $0.49 | |
| EPS (TTM) | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 | $0.91 | $-0.50 | $-0.56 | $0.45 | $-0.81 | $-0.25 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 37.5% | 22.4% | 25.6% | 48.9% | 65.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 28.4% | 31.8% | 45.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -25.4% | 63.3% | 45.8% | -47.4% | 201.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 21.1% | 7.8% | 32.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 23.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -28.6% | 57.7% | 39.3% | -49.8% | 212.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 16.2% | 3.3% | 29.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 19.7% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.02B | $829M | $660M | $443M | $268M | $196M | $152M | $317M | $147M | $135M | $75M | |
| Net Income TTM | $317M | $444M | $282M | $202M | $403M | $129M | $-72M | $-80M | $63M | $-103M | $-32M | $-68M | |
| Market Cap | $7.93B | $5.89B | $4.69B | $7.69B | $5.53B | $5.77B | $2.42B | $2.09B | $2.89B | $1.28B | $2.22B | $1.21B | |
| Enterprise Value | $9.94B | $7.28B | $6.07B | $8.96B | $6.29B | $6.02B | $2.41B | $1.86B | $2.63B | $1.29B | $2.16B | $1.13B | |
| P/E | 26.3 | 13.9 | 17.6 | 39.5 | 14.7 | 46.9 | -35.5 | -26.1 | 45.0 | -12.2 | -69.3 | · | |
| P/S | 5.7 | 5.8 | 5.7 | 11.6 | 12.5 | 21.6 | 12.4 | 13.8 | 9.1 | 8.7 | 16.4 | 16.1 | |
| P/B | 162.4 | 16.2 | 55.9 | 45.3 | 28.1 | 38.2 | 26.4 | 8.4 | 13.9 | -39.4 | 51.6 | 29.3 | |
| P / Tangible Book | · | · | · | · | 28.1 | 38.2 | · | · | · | · | · | · | |
| P / Cash Flow | 12.2 | 12.3 | 12.1 | 32.0 | 18.5 | 104.0 | -28.4 | -42.2 | 21.6 | -25.4 | -59.9 | -25.5 | |
| P / FCF | 12.3 | 12.6 | 12.6 | 32.7 | 18.6 | 108.9 | -27.1 | -38.6 | 21.8 | -23.9 | -56.3 | -24.8 | |
| EV / EBITDA | 20.7 | 13.0 | 17.4 | 32.7 | 22.5 | 40.8 | -37.9 | -27.8 | 31.6 | -16.0 | -83.9 | -18.4 | |
| EV / FCF | 15.4 | 15.5 | 16.3 | 38.1 | 21.1 | 113.6 | -26.9 | -34.4 | 19.8 | -24.1 | -54.8 | -23.1 | |
| EV / Revenue | 7.1 | 7.2 | 7.3 | 13.6 | 14.2 | 22.5 | 12.3 | 12.3 | 8.3 | 8.8 | 16.0 | 15.0 | |
| Earnings Yield | 3.8% | 7.2% | 5.7% | 2.5% | 6.8% | 2.1% | -2.8% | -3.8% | 2.2% | -8.2% | -1.4% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $481M | $377M | $452M | $354M | $326M | $265M | $298M | $290M | $231M | $196M | $230M | $216M | $221M | $162M | $181M | $209M | |
| Cost of Revenue | $79M | $79M | $79M | $55M | $46M | $48M | $42M | $49M | $40M | $28M | $52M | $55M | $50M | $35M | $42M | $47M | |
| R&D Expense | $28M | $26M | · | $17M | $18M | $15M | · | $18M | $21M | $19M | · | $17M | $20M | $18M | $23M | $17M | |
| SG&A Expense | $57M | $58M | $77M | $46M | $42M | $42M | $42M | $41M | $36M | $35M | $38M | $35M | $39M | $37M | $38M | $34M | |
| Operating Expenses | $193M | $192M | $545M | $136M | $123M | $123M | $123M | $127M | $114M | $100M | $129M | $128M | $127M | $108M | $107M | $126M | |
| Operating Income | $288M | $185M | $-93M | $218M | $202M | $142M | $176M | $163M | $117M | $96M | $101M | $88M | $94M | $54M | $75M | $83M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $4M | $5M | · | $8M | |
| Other Non-op | $3M | $1M | $2M | $5M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $852.0K | $641.0K | |
| Pretax Income | $285M | $180M | $-101M | $219M | $205M | $144M | $178M | $165M | $118M | $96M | $101M | $102M | $93M | $52M | $71M | $74M | |
| Income Tax | $55M | $30M | $41M | $44M | $40M | $26M | $41M | $28M | $24M | $19M | $16M | $20M | $18M | $13M | $13M | $12M | |
| Net Income | $230M | $150M | $-142M | $175M | $165M | $118M | $137M | $137M | $93M | $77M | $85M | $82M | $75M | $40M | $58M | $62M | |
| EPS (Basic) | $1.96 | $1.27 | $-1.17 | $1.49 | $1.36 | $0.96 | $1.08 | $1.08 | $0.73 | $0.61 | $0.65 | $0.62 | $0.57 | $0.29 | $0.43 | $0.45 | |
| EPS (Diluted) | $1.90 | $1.22 | $-1.13 | $1.43 | $1.33 | $0.93 | $1.06 | $1.05 | $0.72 | $0.60 | $0.64 | $0.61 | $0.56 | $0.29 | $0.41 | $0.44 | |
| Shares (Basic) | 117,274,000 | 118,144,000 | · | 117,219,000 | 121,343,000 | 123,215,000 | · | 126,850,000 | 127,116,000 | 126,941,000 | · | 131,965,000 | 131,730,000 | 135,027,000 | · | 136,527,000 | |
| Shares (Diluted) | 121,215,000 | 122,875,000 | · | 122,331,000 | 124,158,000 | 126,644,000 | · | 130,134,000 | 129,222,000 | 128,887,000 | · | 134,083,000 | 133,543,000 | 137,900,000 | · | 139,387,000 | |
| EBITDA | $292M | $189M | · | $221M | $205M | $144M | · | $166M | $120M | $98M | · | $91M | $97M | $56M | · | $85M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $310M | $134M | $420M | $62M | $176M | $116M | $154M | $188M | $165M | $118M | $274M | $221M | $96M | · | $147M | |
| Receivables | $453M | $458M | $426M | $344M | $315M | $304M | $288M | $273M | $210M | $185M | · | $214M | $222M | $195M | · | $233M | |
| Inventory | $137M | $155M | $176M | $186M | $182M | $165M | $142M | $131M | $159M | $169M | · | $129M | $132M | $108M | · | $103M | |
| Prepaid Expense | $109M | $71M | $65M | $95M | $77M | $45M | $39M | $44M | $85M | $46M | · | $49M | $39M | $37M | · | $51M | |
| Current Assets | $933M | $1.00B | $825M | $1.33B | $1.12B | $1.26B | $1.09B | $1.13B | $988M | $874M | · | $879M | $766M | $615M | · | $653M | |
| PP&E (Net) | $50M | $47M | $44M | $41M | $40M | $40M | $41M | $40M | $40M | $42M | · | $37M | $36M | $39M | · | $31M | |
| PP&E (Gross) | $84M | $82M | $78M | $72M | $69M | $67M | $66M | $64M | $62M | $63M | · | $56M | $53M | $55M | · | $46M | |
| Accum. Depreciation | $34M | $35M | $33M | $31M | $29M | $27M | $25M | $24M | $22M | $21M | · | $18M | $17M | $16M | · | $15M | |
| Goodwill | $582M | $582M | $580M | $417M | $417M | $417M | $417M | $417M | $417M | $417M | · | $417M | $417M | $416M | · | $199M | |
| Intangibles | $922M | $952M | $981M | $349M | $366M | $384M | $402M | $420M | $437M | $455M | · | $491M | $511M | $529M | · | $949M | |
| Total Assets | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B | $2.12B | $1.97B | $1.84B | · | $1.89B | $1.81B | $1.70B | · | $1.86B | |
| Accounts Payable | $24M | $14M | $21M | $15M | $19M | $20M | $10M | $12M | $15M | $13M | · | $19M | $10M | $9M | · | $18M | |
| Accrued Liabilities | $112M | $140M | $156M | $111M | $116M | $130M | $129M | $96M | $118M | $118M | · | $95M | $105M | $80M | · | $74M | |
| Current Liabilities | $344M | $363M | $177M | $837M | $134M | $150M | $139M | $109M | $133M | $132M | · | $115M | $116M | $92M | · | $109M | |
| Deferred Tax | $49M | $48M | $43M | $8M | · | · | $0 | $12M | $14M | · | · | · | · | · | · | $29M | |
| Other Non-current Liabilities | $103M | $106M | $114M | $72M | $78M | $56M | $55M | $40M | $31M | $31M | · | $28M | $31M | $30M | · | $5M | |
| Total Liabilities | $2.43B | $2.45B | $2.48B | $1.72B | $1.72B | $1.71B | $1.70B | $1.67B | $1.68B | $1.66B | · | $1.64B | $1.66B | $1.63B | · | · | |
| Long-term Debt | $2.15B | $2.14B | $2.14B | $1.51B | $1.51B | $1.51B | $1.51B | $1.50B | $1.50B | $1.50B | · | $1.50B | $1.50B | $1.49B | · | $1.50B | |
| Total Debt | $2.15B | $2.14B | · | $1.51B | $1.51B | $1.51B | · | $1.50B | $1.50B | $1.50B | · | $1.50B | $1.50B | $1.49B | · | $1.50B | |
| Common Stock | $114.0K | $118.0K | $118.0K | $118.0K | $118.0K | $123.0K | $123.0K | $127.0K | $127.0K | $127.0K | · | $132.0K | $132.0K | $132.0K | · | $135.0K | |
| Retained Earnings | $151M | $205M | $55M | $502M | $361M | $478M | $360M | $398M | $261M | $167M | · | $222M | $140M | $66M | · | $86M | |
| AOCI | $-8M | $-13M | $-18M | $-22M | $-28M | $-3M | $4M | $-7M | $-2M | $-1M | · | $1M | $-2M | $24.0K | · | $-2M | |
| Stockholders' Equity | $144M | $220M | $49M | $504M | $333M | $482M | $364M | $453M | $289M | $178M | $84M | $249M | $151M | $66M | $170M | $97M | |
| Liabilities + Equity | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B | $2.12B | $1.97B | $1.84B | · | $1.89B | $1.81B | $1.70B | · | $1.86B | |
| Shares Outstanding | 114,042,000 | 118,523,000 | 117,782,000 | 117,523,000 | 117,621,000 | 123,170,000 | 123,138,000 | 127,183,000 | 126,535,000 | 127,186,000 | · | 132,081,000 | 131,856,000 | 131,662,000 | · | 135,211,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $18M | $17M | $17M | $12M | $12M | $11M | $11M | $13M | $9M | $10M | $10M | $9M | $10M | $8M | $7M | $7M | |
| Amort. of Intangibles | $30M | $30M | $23M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $20M | $18M | $18M | $5M | $27M | |
| Other Non-cash | · | $9M | · | · | · | $23M | · | · | · | $40M | · | · | · | $37M | · | · | |
| Operating Cash Flow | $241M | $180M | $219M | $179M | $100M | $154M | $178M | $115M | $56M | $129M | $102M | $132M | $67M | $87M | $82M | $70M | |
| CapEx | $4M | $4M | $1M | $3M | $2M | $950.0K | $3M | $2M | $3M | $4M | $3M | $3M | $-2M | $11M | $2M | $1M | |
| Investing Cash Flow | $-63M | $-3M | $-742M | $202M | $85M | $-90M | $29M | $-167M | $-42M | $-83M | $-8M | $-83M | $55M | $-60M | $-2M | $-1M | |
| Stock Repurchased | · | · | $0 | $39M | · | · | $250M | $0 | $0 | $0 | $252M | $0 | $0 | $150M | $1.0K | $200M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-150M | · | · | |
| Financing Cash Flow | $-326M | $-2M | $240M | $-22M | $-299M | $-3M | $-246M | $19M | $9M | $-489.0K | $-250M | $4M | $2M | $-165M | $6M | $-12M | |
| Net Change in Cash | $-148M | $176M | $-283M | $358M | $-114M | $60M | $-38M | $-34M | $23M | $46M | $-156M | $53M | $124M | $-138M | $87M | $56M | |
| Free Cash Flow | · | $176M | · | · | · | $153M | · | · | · | $126M | · | · | · | $76M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $122M | · | · | · | $72M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 59.8% | 49.0% | · | 61.5% | 62.2% | 53.4% | · | 56.3% | 50.7% | 48.8% | · | 40.9% | 42.7% | 33.2% | · | 39.9% | |
| Net Margin | 47.8% | 39.8% | · | 49.5% | 50.7% | 44.6% | · | 47.2% | 40.3% | 39.2% | · | 37.9% | 33.8% | 24.4% | · | 29.5% | |
| Pretax Margin | 59.2% | 47.9% | · | 61.8% | 62.9% | 54.3% | · | 56.9% | 50.9% | 49.0% | · | 47.1% | 42.1% | 32.2% | · | 35.3% | |
| EBITDA Margin | 60.7% | 50.1% | · | 62.3% | 63.0% | 54.4% | · | 57.1% | 51.8% | 50.0% | · | 42.1% | 44.0% | 34.8% | · | 40.8% | |
| ROA | 9.9% | 6.2% | · | 8.1% | 8.2% | 5.9% | · | 6.8% | 4.9% | 4.3% | · | 4.4% | 4.2% | 2.8% | · | 4.0% | |
| ROE | 96.5% | 42.8% | · | 36.6% | 53.1% | 35.8% | · | 39.0% | 42.3% | 63.1% | · | 47.3% | 33.7% | 24.3% | · | 32.6% | |
| ROIC | 10.1% | 6.5% | · | 8.7% | 8.9% | 5.8% | · | 6.9% | 5.2% | 4.5% | · | 4.1% | 4.6% | 2.6% | · | 4.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.8 | · | 1.6 | 8.4 | 8.4 | · | 10.4 | 7.4 | 6.6 | · | 7.6 | 6.6 | 6.7 | · | 6.0 | |
| Quick Ratio | 1.8 | 2.1 | · | 0.9 | 2.8 | 3.2 | · | 3.9 | 3.0 | 2.7 | · | 4.2 | 3.8 | 3.2 | · | 3.5 | |
| Debt / Equity | 15.0 | 9.8 | · | 3.0 | 4.5 | 3.1 | · | 3.3 | 5.2 | 8.4 | · | 6.0 | 9.9 | 22.7 | · | 15.5 | |
| LT Debt / Equity | 13.5 | 8.8 | · | 1.6 | 4.5 | 3.1 | · | 3.3 | 5.2 | 8.4 | · | 6.0 | 9.9 | 22.7 | · | 15.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 21.2 | · | 19.6 | 21.0 | 11.8 | · | 11.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.2 | · | 0.5 | 0.4 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.3 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.2 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.26 | $1.85 | · | $4.29 | $2.83 | $3.92 | · | $3.56 | $2.29 | $1.40 | · | $1.89 | $1.15 | $0.50 | · | $0.72 | |
| Revenue / Share | $3.97 | $3.07 | · | $2.90 | $2.62 | $2.09 | · | $2.23 | $1.79 | $1.52 | · | $1.61 | $1.66 | $1.18 | · | $1.50 | |
| Cash Flow / Share | · | $1.47 | · | · | · | $1.22 | · | · | · | $1.00 | · | · | · | $0.63 | · | · | |
| Cash / Share | $1.43 | $2.61 | · | $3.57 | $0.53 | $1.43 | · | $1.21 | $1.48 | $1.29 | · | $2.08 | $1.68 | $0.73 | · | $1.09 | |
| EPS (TTM) | $3.42 | $2.85 | · | $4.75 | $4.37 | $3.76 | · | $3.01 | $2.57 | $2.41 | · | $1.87 | $1.70 | $1.30 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.66B | $1.51B | · | $1.24B | $1.18B | $1.08B | · | $947M | $873M | $863M | · | $781M | $774M | $705M | · | · | |
| Net Income TTM | $414M | $349M | · | $595M | $557M | $485M | · | $392M | $337M | $319M | · | $254M | $234M | $182M | · | · | |
| Market Cap | $8.93B | $7.66B | · | $8.62B | $6.12B | $7.86B | · | $7.28B | $6.63B | $5.17B | · | $5.05B | $4.76B | $5.03B | · | $5.35B | |
| Enterprise Value | $10.91B | $9.50B | · | $9.71B | $7.57B | $9.19B | · | $8.63B | $7.94B | $6.51B | · | $6.27B | $6.03B | $6.43B | · | $6.70B | |
| P/E | 22.9 | 22.7 | · | 15.4 | 11.9 | 17.0 | · | 19.0 | 20.4 | 16.9 | · | 20.4 | 21.2 | 29.4 | · | · | |
| P/S | 5.4 | 5.1 | · | 6.9 | 5.2 | 7.2 | · | 7.7 | 7.6 | 6.0 | · | 6.5 | 6.1 | 7.1 | · | · | |
| P/B | 62.2 | 34.9 | · | 17.1 | 18.4 | 16.3 | · | 16.1 | 22.9 | 29.1 | · | 20.2 | 31.5 | 76.4 | · | 55.1 | |
| P / Cash Flow | · | 42.5 | · | · | · | 51.0 | · | · | · | 40.0 | · | · | · | 57.8 | · | · | |
| EV / Revenue | 6.6 | 6.3 | · | 7.8 | 6.4 | 8.5 | · | 9.1 | 9.1 | 7.5 | · | 8.0 | 7.8 | 9.1 | · | · | |
| Earnings Yield | 4.4% | 4.4% | · | 6.5% | 8.4% | 5.9% | · | 5.3% | 4.9% | 5.9% | · | 4.9% | 4.7% | 3.4% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $1.40B | $1.02B | $829M | $660M | $443M |
| Betriebsgewinnmarge % | 33.6% | 54.3% | 40.7% | 40.5% | 62.2% |
| Nettoergebnis | $317M | $444M | $282M | $202M | $403M |
| Verwässerte EPS | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 43.9 | 4.1 | 17.9 | 8.9 | 4.5 |
| Liquiditätsgrad | 4.7 | 7.8 | 6.6 | 5.7 | 7.9 |
| Quick Ratio | 3.2 | 2.9 | 1.1 | 3.6 | 1.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $645M | $468M | $373M | $235M | $298M |
Institutionelle Eigentümer (13F) 718 Einreicher · $10.0B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
718
Gehaltener Wert
$10.0B
Neue Positionen
98
Geschlossene Positionen
64
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 98 (-21 vs. Vorquartal) | 64 (0 vs. Vorquartal) | 272 (+43 vs. Vorquartal) | 206 (-3 vs. Vorquartal) | +4.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $1.038.728.610 | 13.271.095 | 10,37% | Aktien |
| VANGUARD GROUP INC | $778.452.101 | 11.566.896 | 7,77% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $418.847.190 | 5.351.312 | 4,18% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $414.753.356 | 5.299.008 | 4,14% | Aktien |
| STATE STREET CORP | $405.379.779 | 5.179.434 | 4,05% | Aktien |
| Invesco Ltd. | $248.741.825 | 3.177.997 | 2,48% | Aktien |
| MORGAN STANLEY | $221.707.309 | 2.832.594 | 2,21% | Aktien |
| Boston Partners | $216.820.544 | 2.773.568 | 2,16% | Aktien |
| BANK OF AMERICA CORP /DE/ | $214.503.722 | 2.740.561 | 2,14% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $197.281.725 | 2.519.951 | 1,97% | Aktien |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $196.539.884 | 2.511.050 | 1,96% | Aktien |
| SNYDER CAPITAL MANAGEMENT L P | $187.542.825 | 2.396.101 | 1,87% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $163.542.164 | 2.089.567 | 1,63% | Aktien |
| D. E. Shaw & Co., Inc. | $157.047.112 | 2.006.479 | 1,57% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $151.690.000 | 1.938.035 | 1,51% | Aktien |
| ROYAL LONDON ASSET MANAGEMENT LTD | $141.732.491 | 1.810.815 | 1,42% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $133.420.842 | 1.704.623 | 1,33% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $129.402.617 | 1.653.285 | 1,29% | Aktien |
| UBS Group AG | $116.796.372 | 1.492.224 | 1,17% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $116.700.910 | 1.491.004 | 1,17% | Aktien |
| NORGES BANK | $116.125.129 | 1.483.648 | 1,16% | Aktien |
| FIRST TRUST ADVISORS LP | $110.913.469 | 1.417.063 | 1,11% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $109.647.251 | 1.696.538 | 1,09% | Aktien |
| Stephens Investment Management Group LLC | $109.015.943 | 1.392.819 | 1,09% | Aktien |
| WELLS FARGO & COMPANY/MN | $108.828.836 | 1.390.428 | 1,09% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $103.520.920 | 1.322.613 | 1,03% | Aktien |
| GOLDMAN SACHS GROUP INC | $99.429.825 | 1.270.344 | 0,99% | Aktien |
| FRANKLIN RESOURCES INC | $97.371.010 | 1.244.040 | 0,97% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $96.202.127 | 1.229.106 | 0,96% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $92.656.000 | 1.183.799 | 0,93% | Aktien |
| TD Asset Management Inc | $87.328.187 | 1.115.730 | 0,87% | Aktien |
| Epoch Investment Partners, Inc. | $85.982.100 | 1.098.532 | 0,86% | Aktien |
| NORTHERN TRUST CORP | $85.127.470 | 1.087.613 | 0,85% | Aktien |
| Boston Trust Walden Corp | $84.771.263 | 1.083.062 | 0,85% | Aktien |
| Caisse de depot et placement du Quebec | $83.939.801 | 1.072.439 | 0,84% | Aktien |
| JANUS HENDERSON GROUP PLC | $79.741.989 | 1.233.658 | 0,80% | Aktien |
| Assenagon Asset Management S.A. | $78.085.518 | 997.643 | 0,78% | Aktien |
| FEDERATED HERMES, INC. | $75.298.949 | 962.041 | 0,75% | Aktien |
| BANK OF MONTREAL /CAN/ | $73.764.153 | 942.432 | 0,74% | Aktien |
| Mizuho Markets Cayman LP | $65.316.315 | 834.500 | 0,65% | Aktien |
| Bank of New York Mellon Corp | $62.791.708 | 802.245 | 0,63% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $61.485.452 | 785.556 | 0,61% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $59.930.713 | 765.692 | 0,60% | Aktien |
| Gotham Asset Management, LLC | $57.862.898 | 739.273 | 0,58% | Aktien |
| JANE STREET GROUP, LLC | $54.372.917 | 694.684 | 0,54% | Aktien |
| SEI INVESTMENTS CO | $43.135.607 | 551.116 | 0,43% | Aktien |
| ROYAL BANK OF CANADA | $42.716.000 | 545.761 | 0,43% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $42.656.680 | 544.994 | 0,43% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $41.396.142 | 528.889 | 0,41% | Aktien |
| Nuveen, LLC | $41.238.506 | 526.875 | 0,41% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RANDAL J. KIRK ×14 Einreichungen | 5. November 2019 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 6. Mai 2004 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 48 Insider · 27 Führungskräfte · 19 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Helen Torley | PRESIDENT AND CEO | 11. September 2026 M | 767.780 | 0 | 73 | $-35.535.969 |
| Gregory Ian Frost | CEO, President | 11. Dezember 2013 M | 3.641.380 | 0 | 0 | $0 |
| Jonathan E Lim | Chief Executive Officer | 4. Februar 2010 A | 710.000 | 0 | 0 | $0 |
| Darren Snellgrove | SVP, Chief Financial Officer | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Nicole Labrosse | SVP, CHIEF FINANCIAL OFFICER | 23. Februar 2026 M | 38.494 | 0 | 0 | $0 |
| Laurie Stelzer | SVP, Chief Financial Officer | 22. Februar 2020 M | 116.167 | 0 | 0 | $0 |
| Kurt A Gustafson | Vice President and CFO | 4. Februar 2013 A | 35.667 | 0 | 0 | $0 |
| Cortney Caudill | SVP, CHIEF OPERATING OFFICER | 10. März 2026 M | 7.055 | 0 | 4 | $-2.233.042 |
| Mark J Gergen | SVP, Chief Operating Officer | 22. Februar 2017 A | · | 0 | 0 | $0 |
| David A Ramsay | EVP, PRESIDENT, DRUG DELIVERY | 1. Juli 2026 A | 4.592 | 0 | 0 | $0 |
| Mark Howard Snyder | SVP, CHIEF LEGAL OFFICER | 12. Juni 2026 M | 49.929 | 0 | 0 | $0 |
| Michael J. Labarre | SVP, CHIEF TECHNICAL OFFICER | 27. Februar 2025 S | 173.756 | 0 | 0 | $0 |
| Masaru Matsuda | SVP, General Counsel | 4. September 2021 M | 20.049 | 0 | 0 | $0 |
| Benjamin Hickey | SVP, Chief Commerical Officer | 1. Oktober 2019 M | 13.226 | 0 | 0 | $0 |
| Dimitrios Chondros | SVP, Chief Medical Officer | 3. August 2019 S | 38.584 | 0 | 0 | $0 |
| Alison A. Armour | SVP, Research & Development | 3. Juni 2019 A | · | 0 | 0 | $0 |
| Harry J Leonhardt | SVP, GC | 13. April 2019 M | 66.373 | 0 | 0 | $0 |
| Athena Countouriotis | SVP and Chief Medical Officer | 22. Februar 2017 A | 39.077 | 0 | 0 | $0 |
| James P Shaffer | VP & Chief Commercial Officer | 6. Februar 2014 A | 54.025 | 0 | 0 | $0 |
| Jean I Liu | VP & General Counsel | 6. Februar 2014 A | 20.869 | 0 | 0 | $0 |
| Michael H. Shepard | VP, Chief Scientific Officer | 19. August 2013 S | 13.198 | 0 | 0 | $0 |
| William J Fallon | VP, Manufacturing & Operations | 10. Mai 2011 A | · | 0 | 0 | $0 |
| Robert J Little | VP, Chief Commercial Officer | 4. Februar 2010 A | 13.000 | 0 | 0 | $0 |
| Jonathan A Leff | VP, Chief Medical Officer | 6. August 2009 A | · | 0 | 0 | $0 |
| Richard C Yocum | VP-Clinical Development | 6. Februar 2008 A | 65.975 | 0 | 0 | $0 |
| Don A Kennard | Vice President, Regulatory Aff | 5. Februar 2007 A | 3.000 | 0 | 0 | $0 |
| Carolyn Rynard | Vice President | 9. Februar 2005 M | 100.000 | 0 | 0 | $0 |
| James M Daly | Direktor | 1. Oktober 2026 A | 1.169 | 0 | 0 | $0 |
| Matthew L. Posard | Direktor | 1. Oktober 2026 S | 53.609 | 0 | 8 | $-2.614.227 |
| Dannielle Appelhans | Direktor | 1. September 2026 A | 1.161 | 0 | 0 | $0 |
| Bernadette Connaughton | Direktor | 10. August 2026 S | 40.418 | 0 | 8 | $-839.371 |
| Mahesh Krishnan | Direktor | 29. Juni 2026 M | 14.462 | 0 | 1 | $-547.800 |
| James Paul Lang | Direktor | 5. Mai 2026 A | 4.685 | 0 | 0 | $0 |
| Barbara Gayle Duncan | Direktor | 5. Mai 2026 A | 23.715 | 0 | 0 | $0 |
| Jeffrey William Henderson | Direktor | 5. Mai 2026 A | 36.572 | 0 | 0 | $0 |
| Akiko Moni Miyashita | Direktor | 1. Mai 2025 A | 24.937 | 0 | 0 | $0 |
| Connie Matsui | Direktor | 29. November 2024 G | 183.035 | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Direktor | 5. Mai 2023 A | 66.815 | 0 | 0 | $0 |
| Kenneth J Kelley | Direktor | 14. April 2021 S | 179.833 | 0 | 0 | $0 |
| Kathryn E Falberg | Direktor | 4. Mai 2016 A | 358.253 | 0 | 0 | $0 |
| John Stuart Patton | Direktor | 19. August 2014 M | 179.876 | 0 | 0 | $0 |
| Robert L Engler MD | Direktor | 14. August 2014 M | 273.176 | 0 | 0 | $0 |
| Steven T Thornton | Direktor | 8. Mai 2008 A | 30.000 | 0 | 0 | $0 |
| RANDAL J. KIRK | 10%-Eigentümer | 28. August 2018 S | 1.897.610 | 0 | 0 | $0 |
| Elaine D Sun | · | 1. April 2021 M | 14.018 | 0 | 0 | $0 |
| Matthew Hooper | · | 12. November 2007 A | · | 0 | 0 | $0 |
| Mitch Keeler | · | 10. März 2004 J | 15.000 | 0 | 0 | $0 |
| Mellissa Day | · | 10. März 2004 J | 999 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 85 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| GRPM · Invesco Exchange-Traded Fund Trust | 2,94% | 136.508 SH | 2. Oktober 2026 | Täglich |
| CSMD · Professionally Managed Portfolios | 2,87% | 157.971 NS | 31. Juli 2026 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 2,77% | 107.340 SH | 2. Oktober 2026 | Täglich |
| RFG · Invesco Exchange-Traded Fund Trust | 2,67% | 83.551 SH | 2. Oktober 2026 | Täglich |
| AZTD · Tidal Trust I | 2,45% | 11.232 NS | 31. Juli 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 2,18% | 58.695 SH | 2. Oktober 2026 | Täglich |
| JMID · Janus Detroit Street Trust | 1,93% | 5.526 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,78% | 226.384 NS | 31. Juli 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,64% | 19.528 NS | 31. Juli 2026 | N-PORT |
| RNIN · EA Series Trust | 1,31% | 28.944 NS | 31. Juli 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1,25% | 19.931 NS | 31. Juli 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1,20% | 586 NS | 31. Juli 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1,18% | 150.450 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,93% | 897.190 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,81% | 8.022 SH | 2. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,80% | 47.863 NS | 31. Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,77% | 1.431 NS | 31. Juli 2026 | N-PORT |
| COWG · Pacer Funds Trust | 0,72% | 191.956 NS | 31. Juli 2026 | N-PORT |
| SAWS · ETF Series Solutions | 0,69% | 652 NS | 31. Juli 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,67% | 46.907 NS | 31. Juli 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0,59% | 81.331 SH | 2. Oktober 2026 | Täglich |
| SMDX · Tidal Trust III | 0,58% | 9.164 NS | 31. Juli 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,49% | 117.038 SH | 19. August 2026 | Täglich |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,42% | 23.518 NS | 31. Juli 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,41% | 15.662 SH | 2. Oktober 2026 | Täglich |
| IQSM · New York Life Investments ETF Trust | 0,37% | 14.792 NS | 31. Juli 2026 | N-PORT |
| IWP · iShares Trust | 0,37% | 661.295 SH | 11. September 2026 | Täglich |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,32% | 52.640 NS | 31. Juli 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 16.701 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,29% | 72.153 SH | 2. Oktober 2026 | Täglich |
| PTMC · Pacer Funds Trust | 0,28% | 13.123 NS | 31. Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,25% | 1.570.798 SH | 19. August 2026 | Täglich |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,25% | 191.789 SH | 19. August 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,25% | 19.561 NS | 31. Juli 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,24% | 18.498 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,22% | 654 NS | 31. Juli 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 52.033 NS | 31. Juli 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,21% | 1.742 NS | 31. Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,21% | 62.464 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,20% | 68.924 SH | 11. September 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,20% | 14.085 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,19% | 49.681 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,18% | 325.861 NS | 31. Juli 2026 | N-PORT |
| SMMD · iShares Trust | 0,17% | 62.662 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,15% | 38.778 SH | 19. August 2026 | Täglich |
| LRGF · iShares Trust | 0,15% | 50.426 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,14% | 56.494 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,14% | 356.192 SH | 19. August 2026 | Täglich |
| FTLS · First Trust Exchange-Traded Fund III | 0,13% | 40.141 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,12% | 7.228 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,11% | 2.720.382 SH | 19. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,10% | 1.361.013 SH | 19. August 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 7.065 SH | 2. Oktober 2026 | Täglich |
| IWR · iShares Trust | 0,09% | 482.899 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,09% | 23.542 NS | 31. Juli 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,07% | 8.107 SH | 2. Oktober 2026 | Täglich |
| LRND · New York Life Investments ETF Trust | 0,06% | 2.678 NS | 31. Juli 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,04% | 163.642 SH | 11. September 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 18.538 SH | 2. Oktober 2026 | Täglich |
| IWF · iShares Trust | 0,04% | 441.291 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,04% | 9.947 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,04% | 2.362 NS | 31. Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,03% | 103.928 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,03% | 192.370 NS | 31. Juli 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 185.857 SH | 19. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,02% | 9.295 NS | 31. Juli 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,02% | 26.549 SH | 19. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,02% | 29.890 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 5.290 SH | 9. September 2026 | Täglich |
| IWV · iShares Trust | 0,02% | 33.987 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,02% | 80.773 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,02% | 43.556 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,02% | 152.341 SH | 11. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,01% | 10.186 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.763.482 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 96.181 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19.437 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.862 SH | 19. August 2026 | Täglich |
| IJH · iShares Trust | · | 4.161.889 SH | 11. September 2026 | Täglich |
| IJK · iShares Trust | · | 686.856 SH | 11. September 2026 | Täglich |
| XJH · iShares Trust | · | 16.204 SH | 8. September 2026 | Täglich |
| ISCB · iShares Trust | · | 5.326 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 26.290 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 163.040 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 9.649 SH | 1. September 2026 | Täglich |
HALO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 16 Analysten
KAUF
Median-Ziel
$105.00
-3,1%
3 18,8%
Starker Kauf
10 62,5%
Kauf
3 18,8%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-10-02Mittelwert-Ziel $99.56 -8,1%
Jetzt
Aktueller Preis $108.31
Tief$70.00
Mittelwert$99.56
Hoch$115.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | · |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | · |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | · |
| SMMT | $13.56B | -12.1 | · | · | -235.1% | · |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | · |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | · |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | · |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Abgelaufen
Risiko 1
Belohnung 4,99
Einstieg
$66.52
R:R 4,99
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 5,01
Einstieg
$65.48
R:R 5,01
BLUECHIP_DIP
Abgelaufen
Risiko 1
Belohnung 1,45
Einstieg
$64.19
R:R 1,45
BOUNCE_UP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,50
Einstieg
$71.75
R:R 1,50
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026